Protective benefits are evidenced in the liver, GI tract, cardiovascular system, and nervous system [6, 11, 25]
In the preclinical literature it is described above all as a cytoprotective and pro-angiogenic compound, acting locally within damaged tissue
The extract is standardized to contain a minimum of 13% GR, allowing for the delivery of a consistent, stable form of GR at a calibrated dose, which is ideal for use in clinical studies, as well as in foods and dietary supplements
Public comments supportive of including the measure in the Hospital VBP Program noted the measure is CBE endorsed and that it encourages hospitals to follow published international guidelines for the early identification and management of severe sepsis and septic shock
* Correspondence: Monica Barne, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
